Regeneron Pharmaceuticals
REGN
#380
Rank
HK$514.26 B
Marketcap
HK$4,905
Share price
1.23%
Change (1 day)
22.25%
Change (1 year)

Regeneron Pharmaceuticals (REGN) Fails to deliver data

Key failure to deliver metrics for Regeneron Pharmaceuticals:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Regeneron Pharmaceuticals (REGN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Regeneron Pharmaceuticals (REGN) - since 2013

Volume in USD (price x number of shares), data since 2013

Regeneron Pharmaceuticals (REGN) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026HK$5.05 M-92.73%
2025HK$69.45 M-20.85%
2024HK$87.75 M-26.52%
2023HK$0.11 B-5.6%
2022HK$0.12 B-53.05%
2021HK$0.26 B5.23%
2020HK$0.25 B414.86%
2019HK$49.73 M-31.98%
2018HK$73.11 M69.52%
2017HK$43.12 M-78.72%
2016HK$0.20 B3.03%
2015HK$0.19 B-15.29%
2014HK$0.23 B419.89%
2013HK$44.67 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
HK$85.48 MHK$0.19 B๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$0.10 BHK$0.39 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
HK$0.16 BHK$0.42 B๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$3.1 MHK$45.62 M๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$4.95 MHK$53.4 M๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$12.78 MHK$41.47 M๐Ÿ‡บ๐Ÿ‡ธ USA